I don’t have access to confidential production-cost data for paliperidone (Invega). The exact cost to manufacture it is proprietary and varies widely by contract manufacturer, scale, region, and regulatory/compliance requirements. However, I can outline the main cost drivers and how you could estimate it.
Key cost drivers for paliperidone manufacturing
- Synthesis complexity and yield: Paliperidone is a multi-step small-molecule API with enantiomeric/purity requirements. More steps and lower overall yield drive higher costs.
- Raw materials and reagents: Costs of starting materials, catalysts, chiral reagents, and any specialized solvents or purification aids.
- Purification and quality control: Crystallization, chromatography, impurity profiling, residual solvents testing, and release testing add significant cost.
- GMP facilities and compliance: Cleanroom requirements, validation, environmental controls, QA/QC, stability studies, and batch documentation.
- Scale and efficiency: Larger batches typically reduce per-unit cost, but initial capital investment and downtime for scale-up affect economics.
- IP and contractual terms: Licensing fees, royalties, or access fees if any, plus terms with CMOs.
- Formulation, packaging, and serialization: If you’re talking about the finished drug product (tablet/cill), not just the API, formulation development, excipients, and packaging add costs.
- Regulatory and pharmacovigilance: Documentation, regulatory filings, inspections, and post-market surveillance.
- Supply chain and regional factors: Energy costs, labor, shipping, waste handling, and environmental compliance can vary by country.
- Waste handling and environmental health and safety (EHS): Disposal of hazardous waste and solvent recovery add recurring costs.
How you might estimate it (practical approach)
If you want a rough, order-of-magnitude estimate for budgeting or feasibility, you can build a simple model with these inputs:
- Target batch size (kg of API)
- Overall yield (% per step or for the route)
- Cost of starting materials per kg
- Reagent and solvent consumption per kg API
- Purification cost per kg API (e.g., chromatography, crystallization)
- QC/QA and analytical testing cost per batch
- Labor cost per hour and total labor hours per batch
- Overhead and depreciation (facility, equipment, utilities)
- Regulatory/compliance costs allocated per batch
- Packaging/formulation costs per kg of API (if making finished dosage form)
Simple rough formula (very high level)
Total API manufacturing cost ≈
(Starting materials cost per kg × batch size) +
(Reagents/solvents cost) +
(Purification costs) +
(QC/QA costs) +
(Labor costs) +
(Overhead/depreciation) +
(Regulatory/compliance amortization)
If you want, tell me:
- Are you estimating API-only cost or finished dosage form cost?
- What batch size are you considering (kg of API)?
- Do you have rough yields and cost inputs for starting materials and key reagents?
- What region or CMO setup are you assuming?
With those inputs, I can help you build a simple, transparent cost estimate or compare scenarios (e.g., smaller vs. larger scale). If you need exact figures, you’d typically obtain quotes from CMOs or use market research reports; exact production-cost data for paliperidone is generally not publicly disclosed.